AIC
MGNX icon

Archer Investment Corporation’s MacroGenics MGNX Stock Holding History

Archer Investment Corporation’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100
Closed -$671 – 879
2022
Q4 		$671 Buy
+100
New +$548 ﹤0.01% 778

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Archer Investment Corporation's MGNX Position: Q1 2023 in Review

Archer Investment Corporation sold out of MacroGenics (MGNX) in Q1 2023, closing a stake of 100 shares — an estimated $671 sold.

Archer Investment Corporation first reported a position in MGNX in Q4 2022 and held it in 1 quarter. The position peaked at $671 in Q4 2022. 137 funds tracked by Wall St. Rank hold MGNX as of Q1 2023.

  • Archer Investment Corporation reported no remaining MacroGenics position as of Q1 2023 after selling out during the quarter.
  • Archer Investment Corporation sold 100 MacroGenics shares in Q1 2023, an estimated $671.
  • Archer Investment Corporation first reported a position in MacroGenics in Q4 2022 and held it in 1 quarter.
  • Archer Investment Corporation's MacroGenics position peaked at $671 in Q4 2022.
  • 137 funds tracked by Wall St. Rank held MacroGenics as of Q1 2023.

Based on Archer Investment Corporation's 13F filing for Q1 2023, filed 9 May 2023.